<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00279318</url>
  </required_header>
  <id_info>
    <org_study_id>DK095300; DK100238; DK106955</org_study_id>
    <secondary_id>1UC4DK095300-01</secondary_id>
    <secondary_id>1UC4DK100238-01</secondary_id>
    <secondary_id>1UC4DK106955-01</secondary_id>
    <secondary_id>1UC4DK112243-01</secondary_id>
    <secondary_id>1UC4DK117483-01</secondary_id>
    <secondary_id>1U01DK124166-01</secondary_id>
    <secondary_id>1U01DK128847-01</secondary_id>
    <nct_id>NCT00279318</nct_id>
  </id_info>
  <brief_title>TEDDY - The Environmental Determinants of Diabetes in the Young</brief_title>
  <official_title>Consortium for Identification of Environmental Triggers of Type 1 Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Allergy and Infectious Diseases (NIAID)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute of Environmental Health Sciences (NIEHS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Juvenile Diabetes Research Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centers for Disease Control and Prevention</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The long-term goal of the TEDDY study is the identification of infectious agents, dietary&#xD;
      factors, or other environmental agents, including psychosocial factors which trigger T1DM in&#xD;
      genetically susceptible individuals or which protect against the disease. Identification of&#xD;
      such factors will lead to a better understanding of disease pathogenesis and result in new&#xD;
      strategies to prevent, delay or reverse T1DM.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Epidemiologic patterns suggest that viruses, nutrition, toxic agents or socioeconomic&#xD;
      psychosocial factors may contribute to the etiology alone or in combination. Elucidation is&#xD;
      confounded by the long interval between exposure and onset of clinical disease, as well as&#xD;
      the interaction of multiple genes and/or insults, which appear to interact in a complex&#xD;
      manner. Numerous studies have investigated environmental influences but have yielded&#xD;
      conflicting results. This may be in part due to the failure to account for genetic&#xD;
      susceptibility, begin observation at early ages or in utero, and/or monitor subjects long&#xD;
      term and frequently.&#xD;
&#xD;
      Hypotheses:&#xD;
&#xD;
        1. Initiation of persistent beta-cell autoimmunity and progression from beta-cell&#xD;
           autoimmunity to diabetes is increased with:&#xD;
&#xD;
             1. Exposure to a trigger factor during pregnancy, such as infections, preeclampsia,&#xD;
                blood incompatibility, or birth weight.&#xD;
&#xD;
             2. Differences in the timing of the introduction and/or the type of dietary&#xD;
                constituents that include exposure to cereals or gluten, exposure to cow's milk&#xD;
                during infancy and/or childhood, and short duration of breast- feeding;&#xD;
&#xD;
             3. Lower intake of serum 25 hydroxyvitamin D in early infancy, vitamin E,&#xD;
                anti-oxidants (e.g., carotenoids, ascorbic acid, selenium, or omega-3 fatty acids);&#xD;
&#xD;
             4. Higher frequency of specific (e.g., enterovirus, rotavirus, or bacterial)&#xD;
                infections, or non-specific childhood infections including those that exhibit&#xD;
                molecular mimicry;&#xD;
&#xD;
             5. Increased exposure to routine childhood immunizations and their timing;&#xD;
&#xD;
             6. Environmental factors that may be contained in drinking water (e.g., low&#xD;
                concentrations of zinc or high concentrations of nitrates, or lower pH levels);&#xD;
&#xD;
             7. Exposure to household pets, and various allergies;&#xD;
&#xD;
             8. Excessive weight gain;&#xD;
&#xD;
             9. Increased psychological stress.&#xD;
&#xD;
        2. The risk of persistent beta-cell autoimmunity is lower in children from the general&#xD;
           population than in offspring or siblings of T1DM patients when stratifying for the HLA&#xD;
           DR-DQ genotype and exposure to environmental triggers.&#xD;
&#xD;
        3. The interaction of HLA DR-DQ genotype with exposure to dietary or infectious factors&#xD;
           leads to increased incidence of beta-cell autoimmunity and T1DM.&#xD;
&#xD;
        4. We expect that in some families study participation will be associated with affective&#xD;
           (anxiety, depression) and behavioral responses (e.g. actions to prevent possible T1DM).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>September 2004</start_date>
  <completion_date type="Anticipated">September 2025</completion_date>
  <primary_completion_date type="Anticipated">September 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Appearance of one or more islet cell autoantibodies: GADA, IAA, or IA-2A confirmed at two consecutive visits.</measure>
    <time_frame>September 2025</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Development of T1DM</measure>
    <time_frame>September 2025</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">8668</enrollment>
  <condition>Type 1 Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>General Population, First Degree Relative</arm_group_label>
    <description>Newborns with high risk HLA in the general population or having a first-degree relative affected with T1DM.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum, plasma, PBMCs, stool, urine, saliva, nasal swabs, nail clippings, water, teeth&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Childen up to 4 months of age with specified HLA are enrolled and followed longitudnally&#xD;
        until 15 years of age&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Newborns with high risk HLA in the general population or having a first- degree&#xD;
             relative affected with T1DM&#xD;
&#xD;
          -  Newborns are less than 4 months of age&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Have an illness or birth defect that precludes long-term follow-up or involves use of&#xD;
             treatment that may alter the natural history of diabetes (e.g. steroids or insulin)&#xD;
&#xD;
          -  Refuses to have blood and stool samples stored at the NIDDK Repository&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>4 Months</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeffrey P. Krischer, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of South Florida</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marian J. Rewers, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Colorado Health Science Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>William A. Hagopian, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pacific Northwest Research Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ake Lernmark, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lund University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jorma Toppari, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Turku</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jin-Xiong She, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Augusta University Research Institute, Inc.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Anette G. Ziegler, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Diabetes Research Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Beena Akolkar, PhD</last_name>
    <role>Study Director</role>
    <affiliation>National Institutes of Diabetes and Digestive Kidney Diseases</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Colorado Health Sciences Center</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80262</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Augusta University</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32608</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Augusta University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Augusta University</name>
      <address>
        <city>Augusta</city>
        <state>Georgia</state>
        <zip>30912</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pacific Northwest Research Institute</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98122</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Turku University Central Hospital</name>
      <address>
        <city>Turku</city>
        <zip>20520</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Diabetes Research Institute</name>
      <address>
        <city>Munich</city>
        <zip>80804</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lund University</name>
      <address>
        <city>Malmo</city>
        <zip>20502</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
    <country>Germany</country>
    <country>Sweden</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://teddy.epi.usf.edu/</url>
    <description>TEDDY Study Public site</description>
  </link>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>January 17, 2006</study_first_submitted>
  <study_first_submitted_qc>January 17, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 19, 2006</study_first_posted>
  <last_update_submitted>May 20, 2021</last_update_submitted>
  <last_update_submitted_qc>May 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Environment</keyword>
  <keyword>Exposures</keyword>
  <keyword>Diet</keyword>
  <keyword>Toxins</keyword>
  <keyword>Psychosocial</keyword>
  <keyword>Infectious Agents</keyword>
  <keyword>Bacterial</keyword>
  <keyword>Viral</keyword>
  <keyword>Immunizations</keyword>
  <keyword>Autoantibody</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Data are available at the NIDDK Central Repository https://repository.niddk.nih.gov/studies/teddy/?query=teddy</ipd_description>
    <ipd_url>https://repository.niddk.nih.gov/studies/teddy/?query=teddy</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

